LONDON – The new Edinburgh BioQuarter made the first step toward its aim of becoming Scotland's translational research hub, signing a drug discovery collaboration with GlaxoSmithKline plc in acute pancreatitis.The deal follows a trawl by GSK as it hunts for 10 projects for its recently established university collaboration scheme, the Academic Discovery Performance Unit.